Name: FITC Anti-Mouse CD272 Antibody [PK18.6] (AGEL3185)
SKU: AGEL3185
Availability: OutOfStock

FITC Anti-Mouse CD272 Antibody [PK18.6] (AGEL3185)

(No reviews yet) Write a Review

SKU:

AGEL3185

Description

View AllClose

Additional Information

View AllClose

OverviewProduct Name:FITC Anti-Mouse CD272 Antibody [PK18.6]Product Code:AGEL3186Size:25ug, 100ugClone No:PK18.6

OverviewProduct Name:AF/LE Purified Anti-Mouse CD272 Antibody [PK18.6]Product Code:AGEL2159Clone No:PK18.6Synonyms:B- and T-lymph

OverviewProduct Name:PE/Cyanine7 Anti-Mouse CD272 Antibody [PK18.6] (AGEL2742)Product Code:AGEL2742Clone No:PK18.6Synonyms:B- and

OverviewProduct Name:PE/Cyanine7 Anti-Mouse CD272 Antibody [PK18.6] (AGEL2743)Product Code:AGEL2743Clone No:PK18.6Synonyms:B- and

system_update_altDatasheetOverviewAnti

Isotype:	Rat IgG1, κ
Isotype Control:	FITC Rat IgG1, κ Isotype Control [HRPN]
Conjugation:	FITC
Applications:	FCM
Recommended Dilution:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Storage Buffer:	Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Storage:	Keep as concentrated solution. Store at 2-8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Fluorescent Label:	FITC is designed to be excited by the Blue laser (488 nm) and detected using an optical filter centered near 530 nm (e.g., a 525/40 nm bandpass filter).

Shipping:	Biological ice pack at 4°C
Form:	Liquid
Gene ID:	208154
Swissprot:	Q7TSA3
Background Information:	CD272, also known as B and T lymphocyte attenuator (BTLA), is an Ig superfamily co-inhitory receptor with structural similarity to programmed cell death 1 (PD-1) and CTLA-4. BTLA is expressed on B cells, T cells, macrophages, dendritic cells, NKT cells, and NK cells. Engagement of BTLA by its ligand herpes virus entry mediator (HVEM) is critical for negatively regulating immune response. The absence of BTLA with HVEM inhibitory interactions leads to increased experimental autoimmune encephalomyelitis severity, enhanced rejection of partially mismatched allografts, an increased CD8+ memory T cell population, increased severity of colitis, and reduced effectiveness of T regulatory cells. BTLA plays an important role in the induction of peripheral tolerance of both CD4+ and CD8+ T cells in vivo. Tolerant T cells have significantly higher expression of BTLA compared with effectors and naïve T cells. BTLA may cooperate with CTLA-4 and PD-1 to control T cell tolerance and autoimmunity. It was reported that BTLA may regulate T cell function by binding to B7-H4, but further studies are needed to confirm. The existence of three distinct BTLA alleles has been reported.